98%
921
2 minutes
20
This study synthesizes and characterizes the mononuclear complex [Cu(phen)₂(NO₃)]NO₃·H₂O using analytical techniques such as infrared spectroscopy (FT-IR), elemental analysis, molar conductivity measurements, and single-crystal X-ray crystallography. The complex exhibited 1:1 electrolyte behavior. X-ray crystallography revealed a distorted trigonal bipyramidal geometry around Cu(II), stabilized by two 1,10 phenanthroline ligands and a nitrate ion. Crystallographic data were further analyzed using Hirshfeld surface analysis to quantify intermolecular interactions. The analysis revealed the following percentages: O…H (30.3%) and H…H (25.6%). DNA binding studies using UV-vis absorption spectroscopy demonstrated a hypochromic effect, suggesting a partial intercalative or groove-binding mode due to steric hindrance. The binding constant (K) was determined to be 3.74 × 10 M⁻, indicating a relatively high affinity for DNA. The interaction of the complex with BSA was investigated using UV-vis absorption and fluorescence spectroscopy. Hyperchromism in UV-vis spectra and fluorescence quenching of BSA tryptophan residues were observed, indicating complex binding and conformational changes in BSA. Stern-Volmer analysis revealed a binding-dominated quenching mechanism. Thermodynamic parameters calculated from fluorescence data suggested that van der Waals forces and hydrogen bonding are the dominant interactions in the complex-BSA binding, which was found to be spontaneous and enthalpy-driven. Cyclic voltammetry confirmed the complex's interaction with DNA, showing a decrease in peak currents and negative shifts in peak potentials, further supporting the proposed binding mode.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10895-025-04283-1 | DOI Listing |
J Cereb Blood Flow Metab
September 2025
Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.
Preclinical PET studies offer the opportunity to elucidate molecular mechanisms underlying early neurodevelopment with minimal invasiveness. We demonstrated the feasibility of fetal brain PET in four pregnant rats ( = 42 fetuses). [F]FDG uptake in rat fetuses was readily visualized by PET imaging.
View Article and Find Full Text PDFJ Cereb Blood Flow Metab
September 2025
Achucarro Basque Center for Neuroscience, Leioa, Spain.
Adenosine A receptors (AARs) have shown promising therapeutic properties despite their controversial role in modulating stroke outcome. However, the temporal evolution of cerebral AARs density after cerebral ischemia and its subsequent neuroinflammatory response have been scarcely explored. In this study, the expression of AARs after transient middle cerebral artery occlusion (MCAO) was evaluated in rats by positron emission tomography (PET) with [C]SCH442416 and immunohistochemistry (IHC).
View Article and Find Full Text PDFHum Brain Mapp
September 2025
Cognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, Dresden, Germany.
Acting intentionally is a major aspect of human cognitive development and depends on the ability to link actions with their consequences. Action-effect binding (AEB) is a fundamental mechanism enabling this. While AEB has been well-characterized in adults, its neurophysiological underpinnings during adolescence remain unclear.
View Article and Find Full Text PDFZhong Nan Da Xue Xue Bao Yi Xue Ban
May 2025
Department of Urology, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Objectives: Bladder cancer is a common malignancy with high incidence and poor prognosis. N-methyladenosine (mA) modification is widely involved in diverse physiological processes, among which the mA recognition protein YTH N-methyladenosine RNA binding protein F2 (YTHDF2) plays a crucial role in bladder cancer progression. This study aims to elucidate the molecular mechanism by which O-linked -acetylglucosamine (O-GlcNAc) modification of YTHDF2 regulates its downstream target, period circadian regulator 1 (), thereby promoting bladder cancer cell proliferation.
View Article and Find Full Text PDFZhong Nan Da Xue Xue Bao Yi Xue Ban
May 2025
Department of Information Network Center, Third Xiangya Hospital, Central South University, Changsha 410013, China.
Objectives: Increasing detection of low-risk papillary thyroid carcinoma (PTC) is associated with overdiagnosis and overtreatment. N6-methyladenosine (mA)-mediated microRNA (miRNA) dysregulation plays a critical role in tumor metastasis and progression. However, the functional role of mA-miRNAs in PTC remains unclear.
View Article and Find Full Text PDF